Synlab Services   Report issue

For profit Phase 1 Phase 3
Founded: Manchester United Kingdom (1998)

Organization Overview

First Clinical Trial
2015
NCT02518607
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Phases Clinical Research Limited | SYNLAB Analytics & Services Switzerland AG | SYNLAB Eesti OÜ, Tallinn, Estonia

Active Ingredients

Drugs in Phase 3 Trials (1)

Key: Synlab Services (0) Acquired (1)

fibrinogen (human) (RiaSTAP) (1 trial)

Drugs in Phase 1 Trials (1)

mgb-bp-3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2